BamSEC and AlphaSense Join Forces
Learn More

Eidos Therapeutics, Inc. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 71 pages License Agreement Between Alexion Pharma International Operations Unlimited Company and Eidos Therapeutics, Inc. Dated September 9, 2019
12/34/56
EX-10.1
from 10-Q 29 pages Eidos Therapeutics, Inc. Amended and Restated 2018 Stock Option and Incentive Plan
12/34/56
EX-10.15
from 10-K 14 pages Lease Amendment Number One
12/34/56
EX-10.14
from 10-K 3 pages June 10, 2018 Cameron Turtle via Email Dear Cameron: Eidos Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.2
from 10-K 5 pages Non-Qualified Stock Option Agreement for Company Consultants Under the Eidos Therapeutics, Inc. 2018 Stock Option and Incentive Plan
12/34/56
EX-10.4
from S-1/A 3 pages Eidos Therapeutics, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56
EX-10.3
from S-1/A 15 pages Eidos Therapeutics, Inc. 2018 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 41 pages Eidos Therapeutics, Inc. 2018 Stock Option and Incentive Plan
12/34/56
EX-10.1
from S-1/A 29 pages Eidos Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan Adopted by the Board of Directors: March 31, 2016 Approved by the Stockholders: March 31, 2016 Amended by the Board of Directors: September 7, 2017 Approved by the Stockholders: September 7, 2017 Amended by the Board of Directors: December 22, 2017 Approved by the Stockholders: December 22, 2017 Amended and Restated by the Board of Directors: May 22, 2018 Termination Date: March 31, 2026
12/34/56
EX-10.14
from S-1 7 pages Bonus Agreement
12/34/56
EX-10.13
from S-1 31 pages Qb3@953 Sublease Agreement
12/34/56
EX-10.12
from S-1 47 pages Office Lease by and Between 101 Montgomery Street Co., a California Limited Partnership as Landlord and Eldos Therapeutics, Inc., a Delaware Corporation, as Tenant Premises: 101 Montgomery Street, Suite 2550 San Francisco, California Office Lease
12/34/56
EX-10.11
from S-1 7 pages Intercompany Services Agreement
12/34/56
EX-10.10
from S-1 27 pages Eidos Therapeutics, Inc. Director Indemnification Agreement
12/34/56
EX-10.9
from S-1 31 pages Exclusive (Equity) Agreement
12/34/56
EX-10.8
from S-1 5 pages June 1, 2016 Uma Sinha, PH.D. Dear Uma, Eidos Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.7
from S-1 3 pages December 6, 2017 Christine Siu via Email Dear Christine, Eidos Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.6
from S-1 3 pages Eidos Therapeutics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.5
from S-1 3 pages October 25, 2016 Jonathan C. Fox, MD, PH.D. Dear Jonathan, Eidos Therapeutics, Inc. (The “Company”) Is Pleased to Offer You Employment on the Following Terms
12/34/56
EX-10.2
from S-1 41 pages Eidos Therapeutics, Inc. 2018 Stock Option and Incentive Plan
12/34/56